Skip to content
TrialScanner

NCT03255447

Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy

No phase registeredCompletedFSNUYCollaborator

Registry record

Lead sponsor
Manchester University NHS Foundation Trust
Conditions
Autoimmune Membranous Nephropathy
Primary completion
Apr 3, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03255447 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03255447: Peptide GAM Immunoadsorption... | TrialScanner